Evidence method
Level · gp.fundamentals.debt_to_revenue
142.79% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
DERM · Jun 30, 2026
Journey Medical Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001104659-26-094948General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-9.72% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
18.86% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
45.72% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
65.56% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
2.56% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.30% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
8.06% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20246/8 normalizedLevel 3Dec 31, 20247/9 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 159.37%
- Current
- 142.79%
- Delta
- -16.58%
- Previous
- 18.27%
- Current
- -9.72%
- Delta
- -27.99%
- Previous
- 21.17%
- Current
- 18.86%
- Delta
- -2.32%
- Previous
- 58.36%
- Current
- 45.72%
- Delta
- -12.64%
- Previous
- 60.94%
- Current
- 65.56%
- Delta
- 4.62%
- Previous
- -9.37%
- Current
- 2.56%
- Delta
- 11.93%
- Previous
- 6.21%
- Current
- 8.06%
- Delta
- 1.84%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · Journey Medical Corp →Transitioned To · DERM Fundamental State →Transitioned To · DERM BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · DERM CASH_GENERATION_DECREASED →Transitioned To · DERM GROWTH_DECREASED →Transitioned To · DERM INVENTORY_PRESSURE_DECREASED →Transitioned To · DERM MARGIN_INCREASED →Transitioned To · DERM PROFITABILITY_INCREASED →Transitioned To · DERM SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.